2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Generate Biomedicines said draft copies of three posters for the European Respiratory Society Congress 2026 were made publicly available on the ERS website on August 25, 2026, before the embargo it believed would end on September 7, 2026. The posters present results from ongoing GB-0895 clinical trials, and the company has filed the final posters as Exhibit 99.1 as a precaution.
Draft posters were posted on the ERS website on August 25, 2026; the company believed the embargo would run until 6:01 p.m. Eastern time on September 7, 2026.
The ERS Congress is scheduled for September 5-9, 2026.
Posters cover Phase 1 asthma and COPD data, and the Phase 3 SOLAIRIA-1 and SOLAIRIA-2 asthma studies, with a half-life of about 98 days at 300 mg reported for the asthma data.
Donaldson reported record fourth-quarter fiscal 2026 sales of $1.1 billion, up 8.0%, and GAAP diluted EPS of $1.10, up 13.4%. For fiscal 2027 it forecasts sales growth of 5.5% to 9.5% and EPS of $4.22 to $4.38, compared with fiscal 2026 GAAP EPS of $3.85, reflecting dilution from the Facet acquisition.
Q4 fiscal 2026 sales $1,058.8 million, up 8.0%; GAAP diluted EPS $1.10 versus $0.97; adjusted EPS $1.15 versus $1.03
Full-year fiscal 2026 sales $3.9 billion, up 5.3%; GAAP EPS $3.85, up 26.2%; adjusted EPS $3.98, up 8.2%
Fiscal 2027 guidance: EPS $4.22 to $4.38, including about $0.12 of dilution from Facet; operating margin 16.6% to 17.2%
Full-year fiscal 2026 cash used in acquisitions was $822.6 million, and long-term debt rose to $1,280.0 million from $630.4 million
Exyn Technologies said its former CEO and Chairman, Brandon Torres Declet, resigned effective August 19, 2026, after an internal investigation found about $286,000 in personal expenses charged to a company credit card and recorded as business expenses. Benjamin Williams was named interim CEO and Gregory McNeal became non-executive chairman. Shareholders face a leadership change and a governance problem tied to expense controls and financial records.
Declet agreed to repay the approximately $286,000 in Personal Travel Expenses, and the company agreed to hold off on immediately pursuing legal action to recover them.
Declet will receive no severance, option acceleration, or other special treatment of vested equity under the Separation Agreement dated August 25, 2026.
Benjamin Williams, the company's COO since May 2019, was appointed interim CEO; his base salary was raised from $294,000 to $355,000.
Gregory McNeal, an existing director, was appointed non-executive chairman with an additional cash retainer of $35,000.
The closed-end fund entered into a distribution agreement with ALPS Distributors allowing it to sell up to $75 million of common shares over time through the market, and began the offering on August 25, 2026. Shares may not be sold below net asset value, and the Fund pays the distributor a 1.00% commission on gross sales, so new share issuance could dilute existing holders.
Program size: up to $75,000,000 of common shares with no par value, offered at the market through ALPS Distributors, Inc.
Sub-placement agent UBS Securities LLC was engaged under a sub-placement agreement dated August 25, 2026.
The Fund pays the distributor a commission equal to 1.00% of gross sales price per share sold.
Offering made under a prospectus supplement dated August 25, 2026 and a base prospectus dated August 7, 2026 on Form N-2 (File No. 333-298123).
Karman Line Acquisition Corp., a blank check company, completed its initial public offering of 20,000,000 units at $10.00 per unit on August 19, 2026, with $200 million placed in a trust account for public shareholders. The filing names Karman Line, not Xterax Corp II, so it could not be matched to the XTER ticker in the document; the company has not yet selected a business combination target.
IPO of 20,000,000 units at $10.00 per unit completed August 19, 2026, with $200 million placed in trust
Private placement of 650,000 units at $10.00 per unit, generating $6.5 million gross proceeds
Trust funds can be released only for a business combination, taxes, or redemptions; otherwise redeemed if no deal within 21 months
Audited balance sheet as of August 19, 2026 shows $2.5 million cash and $8 million deferred underwriting commissions
Kohl's created a new Chief Customer Officer role and promoted Arianne Parisi, its Chief Digital Officer, to Senior Executive Vice President in that role, effective September 1, 2026. The role combines marketing and digital customer functions, and Chief Marketing Officer Christie Raymond's position was eliminated, with her employment ending September 9, 2026. The filing contains no financial results or guidance, so the change is a leadership and organizational update rather than a financial one.
Arianne Parisi promoted to Senior Executive Vice President, Chief Customer Officer, effective September 1, 2026, and designated an executive officer
Parisi leads omnichannel customer experience, including marketing, loyalty, personalization, media, digital commerce, Kohls.com and the Kohl's App
Christie Raymond's Chief Marketing Officer position eliminated; employment ends September 9, 2026, with separation benefits under her 2022 agreement
Strattec reported fiscal fourth-quarter 2026 sales of $151.8 million, roughly flat from $152.0 million a year earlier, and GAAP diluted earnings per share of $0.95 versus $2.01. For the full fiscal year, sales rose to $579.4 million from $565.1 million and gross margin expanded to 16.5% from 15.0%, while the company authorized a new $40 million share buyback.
Q4 net income attributable to Strattec was $3.9 million, or $0.95 per diluted share, versus $8.3 million, or $2.01, a year earlier; adjusted diluted EPS was $2.06, unchanged.
Q4 gross margin fell to 15.6% from 16.7%; Q4 Adjusted EBITDA was $12.5 million versus $13.0 million.
Fiscal 2026 Adjusted EBITDA was $50.5 million, a 15.3% increase over the prior year.
The company had $108.2 million in cash and no debt at June 28, 2026, and repurchased $7.4 million of shares in the fourth quarter.
HEICO reported record third-quarter fiscal 2026 results for the three months ended July 31, 2026. Net income rose 33% to $235.4 million, or $1.67 per diluted share, from $1.26 a year earlier, while net sales rose 23% to a record $1,413.1 million. The company said it expects increased net sales at both segments for the rest of fiscal 2026, but the filing gives no numeric guidance.
Q3 net income $235.4 million, or $1.67 per diluted share, versus $1.26 in Q3 fiscal 2025
Q3 net sales $1,413.1 million, up 23%, including 14% consolidated organic growth
Operating margin improved to 25.1% from 23.1%; operating cash flow rose 49% to $345.3 million
Issued $550 million 4.950% senior notes due 2031 and $650 million 5.400% senior notes due 2036, using proceeds to repay revolver borrowings
Ensysce Biosciences said Nasdaq determined on August 25, 2026 that it complies with the $2.5 million stockholders' equity requirement, but the company remains subject to delisting if it does not evidence compliance in its next periodic report. Nasdaq also granted an extension on the minimum bid price rule to February 22, 2027, and said the Cy Biopharma transaction triggers a change of control requiring the post-transaction company to meet initial listing criteria, with trading suspension possible if it does not.
Nasdaq determined on August 25, 2026 that the company complies with the $2.5 million stockholders' equity requirement, but delisting remains possible if compliance is not evidenced in the next periodic report
Nasdaq granted an additional 180 calendar days, until February 22, 2027, to regain the $1.00 minimum bid price requirement
Nasdaq said the Cy Biopharma transaction, completed August 5, 2026, is a change of control requiring an initial listing application; failure could lead to trading suspension
The company intends to submit an initial listing application in a timely manner
Hope Bancorp and Bank of Hope signed an extension of CEO Kevin S. Kim's employment agreement on August 24, 2026, keeping him as President and CEO of the company and CEO of the bank. The extension sets the initial term end date at August 31, 2031, and caps automatic renewals at August 31, 2033. The filing discloses continuity in top leadership and a longer contract term but no change in pay or other financial terms.
Extension signed August 24, 2026 with CEO Kevin S. Kim
Initial term of the employment agreement now ends August 31, 2031, unless sooner terminated
Automatic renewals cannot extend the term beyond August 31, 2033
On August 20, 2026, subsidiary Foothills Rare Earths, LLC assumed the Weyerhaeuser mining lease from Southeast Metals LLC after exercising its option to acquire it. The company paid $375,000 in cash and 165,153 common shares, matching the $2 million in stock consideration it had previously disclosed. The lease covers about 1,662.8 acres in Georgia and carries a 5% royalty on rare earth products, so shareholders should note both the added mineral rights and the new share issuance.
Assignment dated August 20, 2026; Foothills Rare Earths assumed lease obligations required on or after that date.
Consideration: $375,000 in cash plus 165,153 common shares, representing the $2 million in stock previously disclosed; shares issued in a private placement.
Lease covers about 1,662.8 acres in Harris and Talbot Counties, Georgia; annual rent of $75,000 starts in year four, plus a 5% royalty on rare earth products.
First Amendment to the lease, dated January 30, 2026, is filed as Exhibit 10.2.
Tractor Supply Company issued and sold $500 million of 5.200% senior unsecured notes due January 30, 2032, on August 25, 2026, under an underwriting agreement dated August 19, 2026. The company said it intends to use the net proceeds to repay borrowings under its senior credit facility and for general corporate purposes, so the offering adds long-term debt while shifting borrowings from the credit facility to fixed-rate notes.
$500 million principal of 5.200% senior notes issued August 25, 2026, under an underwriting agreement dated August 19, 2026, with Wells Fargo Securities and BofA Securities as representatives
Interest is paid semi-annually on January 30 and July 30, starting January 30, 2027; maturity is January 30, 2032
Net proceeds will repay borrowings under the senior credit facility and fund general corporate purposes; some underwriter affiliates are lenders under that facility and will receive at least 5% of net proceeds
Before December 30, 2031, the company may redeem the notes at the greater of par or a Treasury-based price plus 15 basis points; holders may require repurchase at 101% of principal upon a change of control triggering event
Core Laboratories director Kwaku Temeng confirmed in an August 25, 2026 letter that he will resign from the Board effective October 1, 2026. He chairs the Nominating Committee and sits on the Compensation Committee, and his letter cites a disagreement with the Board over strategic direction and certain governance practices.
Kwaku Temeng first notified the Board verbally on August 19, 2026, and confirmed his resignation by letter on August 25, 2026.
Resignation is effective October 1, 2026; he serves as Chairman of the Nominating Committee and as a member of the Compensation Committee.
The Board says the main disagreement involves how the Company handles succession planning, a process a majority of directors supports; the Board also says he has concerns about research priorities.
Temeng has served on the Board for more than five years; his resignation letter is filed as Exhibit 17.1.
Renasant Corporation said Catherine Mealor, a Managing Director at Keefe, Bruyette & Woods, will join as Executive Vice President and Chief Financial Officer on October 5, 2026, and become CFO on January 1, 2027. James C. Mabry IV, CFO since August 2020, will retire as CFO on December 31, 2026, and the Board intends to nominate him as a director at the 2027 Annual Meeting of Shareholders.
Mealor joins October 5, 2026 and becomes CFO of Renasant and Renasant Bank on January 1, 2027.
Mealor's employment agreement sets a $600,000 base salary, a $400,000 cash signing award and stock valued at $450,000, and a two-year initial term.
Her target annual bonus is 75% of base salary under the Performance-Based Rewards Plan, starting with periods on or after January 1, 2027.
Mabry will serve as Executive Advisor from January 1, 2027 and is expected to serve in that role until the 2027 Annual Meeting.
LSI Industries' Compensation Committee adopted a FY2027 long-term incentive plan and a FY2027 short-term incentive plan on August 19, 2026. It also granted CEO James Clark a $3,000,000 retention award and raised his base salary to $900,000, effective September 1, 2026. The awards tie executive pay to Adjusted EBITDA, Net Sales and return on net assets over fiscal 2027 through 2029.
CEO James Clark's FY2027 LTIP target is $2,500,000, with 41,563 RSUs and 62,344 PSUs granted
Clark's $3,000,000 retention RSU award cliff vests on the third anniversary of the grant date, with an early vesting option if the Board approves a five-year strategic plan before the first anniversary
Clark's annual base salary increases to $900,000 effective September 1, 2026, and his STIP bonus target is 100% of base salary
On August 25, 2026, Huntsman stockholders voted to adopt the Merger Agreement with Olin Corporation, with 131,502,454 votes for and 1,828,828 against. The companies will implement the combination as a direct merger, and the transaction is expected to close in the first half of 2027, subject to regulatory approvals and other closing conditions.
Merger proposal: 131,502,454 for, 1,828,828 against, 378,859 abstentions
Advisory vote on merger-related executive pay: 117,592,172 for, 15,456,713 against, 661,256 abstentions
Quorum of 133,710,141 votes, or 76.23% of the 175,381,417 shares entitled to vote as of the July 9, 2026 record date
Expected closing in the first half of 2027, subject to required regulatory approvals
Oportun Financial's Compensation and Leadership Committee approved an Amended and Restated Executive Severance and Change in Control Policy effective August 19, 2026, replacing the policy effective November 29, 2018. The amended policy covers CEO Douglas Bland and other designated senior vice president-level and above employees, and sets out severance benefits for terminations without Cause or resignations for Good Reason.
Amended policy effective August 19, 2026, replacing the policy effective November 29, 2018.
CEO and Tier I participants receive 18 months of base salary continuation and COBRA premiums, plus 150% of target annual bonus, if terminated during the change-in-control period.
Tier II participants receive 12 months of base salary and COBRA premiums, plus 100% of target annual bonus, during the change-in-control period.
Benefits are subject to a release of claims and other customary conditions; the full policy is filed as Exhibit 10.1.
Exelon announced an executive reshuffle. Robert Kleczynski becomes Chief Financial Officer on Oct. 5, 2026, succeeding Jeanne Jones, who becomes Executive Vice President of Finance and Strategy. Mike Innocenzo, Chief Operating Officer and PECO's interim president and CEO, will depart in 2027 on a date to be determined. In the same filing, Exelon reaffirmed its 2026 adjusted operating earnings guidance of $2.81-$2.91 per share.
Robert Kleczynski becomes CFO and principal financial officer effective Oct. 5, 2026, with a base salary of $650,000 and a long-term incentive target of $1,765,000
Michael Innocenzo will leave his roles as Chief Operating Officer, PECO president and CEO, and ComEd board chair in 2027, date to be determined
Exelon reaffirmed 2026 adjusted operating earnings guidance of $2.81-$2.91 per share and expects 2025-2029 adjusted operating earnings growth near the top of the 5 to 7 percent range
Syntec Optics' Audit Committee dismissed CBIZ CPAs as its independent auditor effective August 19, 2026, and appointed WithumSmith+Brown, PC as successor. The filing discloses several material weaknesses in internal control over financial reporting that CBIZ CPAs identified, including gaps in journal entry review, related-party transaction controls and cybersecurity-related IT controls.
Audit Committee approved the dismissal of CBIZ CPAs P.C. and the appointment of WithumSmith+Brown, PC on August 19, 2026
CBIZ CPAs' audit report on fiscal 2025 financial statements contained no adverse opinion, disclaimer, or qualification
Reportable events include material weaknesses in journal entry review, account reconciliations, related-party transactions, non-routine transactions and IT general controls
Withum's engagement begins with the review of the quarter ending September 30, 2026 and covers the fiscal 2026 audit
Shareholders of Future Vision II Acquisition Corp. approved amending its governing documents at an August 21, 2026 meeting, extending the deadline to complete a business combination to September 13, 2026, with monthly extensions up to September 13, 2027. Holders of 1,866,403 public shares tendered them for redemption, with an aggregate payment of approximately $20,586,425.09 (about $11.3 per share) from the trust account, leaving approximately $42,868,763.91 in the trust.
Proposals 1 and 2 each received 5,288,386 votes for and 630,276 against, with no abstentions
Deadline extended to September 13, 2026, with up to twelve one-month extensions to September 13, 2027
1,866,403 public shares tendered for redemption; 3,883,597 ordinary shares remain outstanding
The company continues to work toward its merger with MicroTouch Technology Inc., under a merger agreement dated January 16, 2026
DLH Holdings disclosed agreements with former President and CEO Zachary C. Parker, who left the role effective June 30, 2026. The filing sets out a separation agreement, a $187,550 transition advisory contract through September 30, 2026, and a consulting arrangement starting October 1, 2026 with equity grants valued at $850,000 in total.
Parker's employment ended June 30, 2026; he remains a non-employee board member through his current term.
Advisory agreement pays Z Parker Enterprises LLC an aggregate $187,550 in three monthly installments, effective July 1, 2026.
Consulting agreement runs October 1, 2026 through September 30, 2027, with 142,857 RSUs valued at $750,000 and 19,047 PSUs valued at $100,000.
Ryman Hospitality Properties and its operating partnership issued $700 million of 6.250% Senior Notes due 2035 under a new indenture dated August 25, 2026. Proceeds are intended to help fund an approximately $1.38 billion acquisition of the JW Marriott Orlando Grande Lakes Resort and The Ritz-Carlton Orlando, Grande Lakes, with the rest coming from a recent stock offering and cash on hand. The added debt increases the company's borrowing obligations, and the notes must be redeemed if the acquisition is not completed.
$700 million aggregate principal of 6.250% Senior Notes due February 15, 2035
Proceeds intended to fund part of an approximately $1.38 billion purchase of the Orlando Grande Lakes properties
Balance funded by proceeds of a 5,865,000-share offering at $117.00 per share, closed August 12, 2026, and cash on hand
Notes subject to special mandatory redemption at 100% of issue price plus accrued interest if the acquisition is not completed
B&R Technology Merger Corp. said the underwriter partially exercised its over-allotment option on August 24, 2026, buying 3,500,000 additional units at $10.00 each for $35 million. Total units sold in the initial public offering rose to 36,000,000, with $360 million placed in a U.S.-based trust account, and the underwriter forfeited the remaining option.
August 24, 2026: 3,500,000 over-allotment units sold at $10.00 per unit, for $35,000,000 in additional gross proceeds
Total IPO: 36,000,000 units and $360,000,000 in gross proceeds, with $360,000,000 placed in trust with Continental Stock Transfer & Trust Company
Sponsor bought 52,500 additional private placement units for $525,000; 458,333 Class B shares were surrendered and cancelled
Remaining option for 1,375,000 units was forfeited
DraftKings closed a second amendment to its credit agreement on August 25, 2026, adding a $700 million Term Loan B due 2033 and a $750 million revolving credit facility maturing in 2031. The revolver replaces an existing $500 million facility scheduled to mature in November 2029. The company plans to use the term loan proceeds to repurchase part of its 0% convertible notes due 2028, subject to market conditions, and for general corporate purposes.
Term Loan B of $700 million, up from the previously announced $600 million, due August 2033, priced at Term SOFR plus 2.00% and offered at 99.50% of par
New $750 million revolving credit facility maturing August 25, 2031, replacing the $500 million facility due 2029
Planned use of term loan proceeds: repurchases of part of the 0% Convertible Senior Notes due 2028, subject to availability and market conditions
Sun Communities appointed Robert A. Garechana, currently executive vice president and chief investment officer at Equity Residential, as its new chief financial officer, effective September 8, 2026. Current CFO Fernando Castro-Caratini moves to an advisory role through October 31, 2026, and the company will pay him severance under his existing agreement.
Garechana, age 47, was Equity Residential's CFO from 2018 to 2025 and its treasurer from 2008 to 2018.
Base salary is $625,000, with a target annual bonus of 150% of base salary.
Start-date equity grant has a target grant date value of $2,500,000, with 30% time-vesting over three years and 70% performance-vesting after three years.
Castro-Caratini remains an advisor through October 31, 2026.
Marten Transport amended its unsecured revolving credit agreement on August 19, 2026, extending the term to August 19, 2031 and raising the letter of credit sublimit to $50 million. The amendment also lowers the maximum aggregate principal amount to $100 million from $105 million and updates the margins for Term SOFR advances. For shareholders, the filing shows a longer borrowing term and a smaller maximum facility size, and the full Second Amendment will be filed with the next Form 10-Q.
Second Amendment dated August 19, 2026 extends the credit agreement term to August 19, 2031.
Letter of credit sublimit increases to $50 million from $35 million.
Maximum aggregate principal amount decreases to $100 million from $105 million; a Second Amended and Restated Revolving Note allows up to $50 million.
Full Second Amendment will be attached to Marten's next Quarterly Report on Form 10-Q.
QumulusAI reported unaudited results for the quarter ended June 30, 2026, its first quarterly report since trading on the Nasdaq Global Market began July 16, 2026. Revenue rose 118% year over year to $6.7 million, but the company posted a net loss of $22.8 million, compared with net income of $12.1 million a year earlier, due in part to a $19.2 million non-cash loss on convertible notes.
Revenue of $6.7 million, up 118% from $3.1 million; gross margin 67% versus 55%
Operating loss of $7.7 million versus $2.2 million, driven by a $5.8 million rise in depreciation and amortization
Net loss of $22.8 million, or $0.72 per share, versus net income of $12.1 million
Signed 21 new direct customer contracts with aggregate expected take-or-pay value of $169.7 million
Electromed reported record fiscal 2026 results, with net revenues up 15.3% to $73.8 million and net income up to $11.3 million, or $1.30 per diluted share. The company also said CEO and director Jim Cunniff plans to retire on or about April 2, 2027, and the board has begun a search for his successor.
FY 2026 net revenues rose 15.3% to $73.8 million; operating income rose 43.7% to $13.9 million
Q4 FY 2026 net income rose 54.3% to $3.4 million, or $0.39 per diluted share
Cash from operations fell to $9.7 million from $11.4 million; the company repurchased $3.9 million of stock
CEO Jim Cunniff expects to retire on or about April 2, 2027 and will leave the board upon retirement
nCino reported second-quarter fiscal 2027 results for the period ended July 31, 2026, with total revenues up 8% and GAAP operating income of $13.6 million, compared with a $9.3 million loss a year earlier. The board also authorized an additional $100 million stock repurchase program, and the company issued revenue and profit guidance for the third quarter and fiscal 2027.
Total revenues were $161.0 million, up 8% from $148.8 million; subscription revenues were $143.5 million, up 10%.
GAAP income from operations was $13.6 million versus a $9.3 million loss in the prior-year quarter; non-GAAP operating income was $40.8 million, up 36%.
The board authorized a new repurchase program of up to $100 million of common stock, following $300 million in repurchases since April 2025.
Third-quarter total revenues are guided to $161.25 million to $163.25 million; fiscal 2027 total revenues are guided to $644.0 million to $647.0 million.
Box reported second-quarter fiscal 2027 revenue of $321.1 million, up 9% from a year earlier, with GAAP diluted earnings per share of $0.09 versus $0.05 and non-GAAP diluted EPS of $0.40 versus $0.33. The company guided to third-quarter revenue of about $329 million and full-year fiscal 2027 non-GAAP EPS of about $1.54, and it repurchased 2.6 million shares for about $66 million in the quarter.
Revenue of $321.1 million, up 9%, or 11% in constant currency
GAAP diluted EPS of $0.09 vs. $0.05; non-GAAP diluted EPS of $0.40 vs. $0.33
Q3 fiscal 2027 revenue guidance of about $329 million; full-year revenue guidance of about $1.290 billion
Repurchased 2.6 million shares for about $66 million; about $378 million of buyback capacity remained as of July 31, 2026
Semtech reported second-quarter fiscal 2027 results for the quarter ended July 26, 2026, with net sales of $341.9 million, up 33% from a year earlier and up 17% from the prior quarter. GAAP net income was $160.1 million, which included a $101.4 million income tax benefit, compared with a net loss of $27.1 million a year earlier. The company also guided third-quarter net sales to $410.0 million plus or minus $5.0 million and adjusted diluted EPS to $1.05 plus or minus $0.03.
Net sales of $341.9 million, up from $257.6 million in Q2 FY2026 and $291.0 million in Q1 FY2027.
GAAP diluted EPS of $1.59, compared with a loss of $0.31 a year earlier; the quarter included a $101.4 million tax benefit.
Non-GAAP adjusted diluted EPS of $0.71, up from $0.41 in Q2 FY2026.
Q3 FY2027 outlook: net sales of $410.0 million plus or minus $5.0 million; adjusted diluted EPS of $1.05 plus or minus $0.03.
Zoom reported fiscal second-quarter 2027 results for the three months ended July 31, 2026. Revenue rose 4.9% to $1,277.2 million and non-GAAP diluted earnings per share rose to $1.55 from $1.53, while GAAP diluted EPS reached $5.15 mainly because of $1,614.2 million in gains on strategic investments. The company also updated its full fiscal 2027 outlook, which now calls for total revenue of $5.085 billion to $5.095 billion.
Total revenue $1,277.2 million, up 4.9%; Enterprise revenue $787.5 million, up 7.8%
GAAP net income $1,542.4 million ($5.15 per diluted share), versus $358.6 million ($1.16) a year earlier
GAAP income from operations $314.3 million, down from $321.7 million; free cash flow $472.4 million, down from $508.0 million
Full fiscal 2027 guidance: revenue $5.085 billion to $5.095 billion; non-GAAP diluted EPS $6.08 to $6.12
CB Financial Services' bank subsidiary, Community Bank, signed new employment agreements on August 24, 2026 with CEO John H. Montgomery and Chief Banking Officer Bruce Sharp, plus a new split dollar life insurance agreement with Mr. Montgomery. The filing describes routine contract terms, including severance and change-in-control provisions, that matter to shareholders mainly as a record of executive compensation and potential payouts.
Mr. Montgomery's base salary is $495,000 and Mr. Sharp's is $294,500; the agreements have initial terms ending April 30, 2029.
If an executive is terminated without cause or resigns for good reason, a lump sum equal to base salary for the remaining term or 12 months, whichever is greater, applies.
After a change in control, the payout would instead be three times the sum of highest base salary and average annual cash bonus, plus up to 24 months of COBRA or Medicare premium reimbursement.
Vyome Holdings reported its second-quarter 2026 results, showing a net loss of approximately $720,000, or $0.10 per share, and total operating expenses of approximately $874,000. The company's cash and cash equivalents rose to approximately $7.9 million from $5.0 million at December 31, 2025, but the six-month net loss widened to $1,705,204 from $602,732 a year earlier, and six-month revenue fell to $58,546 from $248,535.
Q2 2026 net loss attributable to common shareholders: approximately $720,000, or $0.10 per basic and diluted share
Cash and cash equivalents: approximately $7.9 million at June 30, 2026, up from $5.0 million at December 31, 2025
Six-month net loss: $1,705,204 in 2026 versus $602,732 in 2025; six-month revenues: $58,546 versus $248,535
Company received the FDA's written response on its VT-1953 clinical development program during the second quarter
Credit Acceptance completed a $600.0 million asset-backed, non-recourse secured financing dated August 20, 2026, backed by consumer loans with a value of about $750.2 million. The company expects an average annualized cost of about 5.5% including upfront fees, and will use the proceeds to repay higher-cost debt and for general corporate purposes.
Three note classes: A $319.9 million at 5.01%, B $117.3 million at 5.29%, C $162.8 million at 5.51%
Financing revolves for 24 months, then amortizes based on cash flows from the conveyed loans
Company says it had about $1.8 billion in unused revolving credit capacity and unrestricted cash after the deal
Debt is non-recourse to the company, apart from limited repurchase and indemnification obligations
flyExclusive appointed Michael Guina as Chief Operating Officer effective August 24, 2026, as part of a transition in which Matthew Lesmeister, the prior COO, will remain with the company as President of Maintenance. The filing states that neither executive receives additional compensation because of the transition, and their September 26, 2024 employment agreements remain in effect. The filing describes a senior operations leadership change and does not report any financial results.
Michael Guina appointed Chief Operating Officer effective August 24, 2026; the appointment was made August 19, 2026
Guina, age 67, joined the company in April 2015 and most recently served as Chief Commercial Officer from September 2024
Matthew Lesmeister, COO until August 24, 2026, will remain with the company as President of Maintenance
No additional compensation provided for the transition; employment agreements dated September 26, 2024 remain in effect
Manitowoc filed an 8-K furnishing an investor presentation for the Midwest IDEAS Investor Conference on August 26, 2026, which includes updated 2026 full-year guidance. The updated ranges are higher than prior guidance for net sales, adjusted EBITDA and adjusted diluted net loss per share, with adjusted EBITDA including a $16 million net benefit from tariff refunds.
Updated 2026 net sales guidance is $2.3 billion to $2.4 billion, up from $2.25 billion to $2.35 billion.
Updated adjusted EBITDA guidance is $150 million to $170 million, including a $16 million net benefit from tariff refunds, up from $125 million to $150 million.
Updated adjusted diluted net loss per share guidance is $0.80 to $1.20, up from $0.45 to $0.90.
The presentation is scheduled for Wednesday, August 26, 2026, at 12:15 PM ET, and the company states $29 million remains on its approved share repurchase plan.
Intuit reported fiscal 2026 fourth-quarter revenue of $4.4 billion, up 14%, and full-year revenue of $21.4 billion, up 14%. Fourth-quarter GAAP operating income rose to $475 million from $339 million, but the company booked a $293 million restructuring charge and GAAP diluted EPS was $1.34 versus $1.35 a year earlier. The company also gave fiscal 2027 guidance for revenue of $23,279 million to $23,512 million, and its board approved a $1.38 quarterly dividend.
Q4 FY2026 total revenue was $4.4 billion, up 14%; full-year GAAP diluted EPS was $16.46, up 20%.
Q4 GAAP operating income was $475 million, including a $293 million restructuring charge; Q4 GAAP diluted EPS was $1.34 versus $1.35 a year earlier.
FY2027 GAAP revenue guidance is $23,279 million to $23,512 million; non-GAAP guidance now includes share-based compensation.
Quarterly dividend of $1.38 per share is payable October 16, 2026, to holders of record on October 8, 2026.
Maison Solutions Inc. (Nasdaq: MSS) received a Nasdaq letter on August 20, 2026, saying it is not in compliance with listing rules because it did not timely file its Form 10-K for the fiscal year ended April 30, 2026. The letter has no immediate effect on the listing of the Class A common stock, which continues to trade on The Nasdaq Capital Market, but the company must still submit a compliance plan.
Nasdaq cited Listing Rule 5250(c)(1), which requires timely filing of periodic reports, after the Form 10-K for the year ended April 30, 2026 was not filed on time.
The company has until October 19, 2026 to submit a plan to regain compliance.
If Nasdaq accepts the plan, it may grant an exception until February 9, 2027; if not, the company may appeal to a Nasdaq Hearings Panel.
The company said it is working diligently to complete the Form 10-K and intends to submit the plan within the 60-day period.
The Cato Corporation reported second-quarter 2026 net income of $1.1 million, or $0.06 per diluted share, down from $6.8 million, or $0.35, a year earlier, as sales fell 6% to $163.9 million. Chairman and CEO John Cato said pressure on customers' discretionary income will continue and that he anticipates the back half of 2026 to be challenging, which weighs on the outlook for shareholders.
Q2 sales were $163.9 million, down 6% from $174.7 million, with same-store sales down 3.7%.
Q2 gross margin fell to 32.8% of sales from 36.2% due to lower merchandise margins and occupancy cost deleverage.
Six-month net income was $10.5 million, or $0.53 per diluted share, versus $10.1 million, or $0.51, a year earlier, on sales down 2.9% to $333.3 million.
The company closed eight stores in the quarter and had 1,057 stores as of August 1, 2026, versus 1,101 a year earlier.
Zymeworks announced that its partner Jazz Pharmaceuticals received FDA approval for two Ziihera regimens as first-line treatment of HER2-positive gastroesophageal adenocarcinoma. Zymeworks earned a $250 million milestone payment from Jazz on the approval and remains eligible for up to $1.3 billion in further milestones plus tiered royalties of 10% to 20% on Jazz's net sales. The filing does not report revenue, profit or guidance figures for the period.
FDA approved Ziihera plus tislelizumab and chemotherapy, and Ziihera plus chemotherapy, as first-line HER2+ GEA treatments, announced August 25, 2026
Zymeworks earned a $250 million milestone payment from Jazz; total payments from Jazz are $650 million to date
Zymeworks remains eligible for up to $1.3 billion in additional Jazz milestones and up to $144 million in BeOne milestones
Marqeta, Inc. (NASDAQ: MQ) appointed Eugenia Gibbons as Chief Product Officer, effective August 31, 2026, to lead the company's product organization. She joins from Intuit, where she was General Manager of the Consumer Money Business, and her pay package includes a $475,000 base salary and equity awards for shareholders to note.
Effective date: August 31, 2026; Gibbons will lead strategy, design, and execution across the product suite.
Prior roles include Intuit (General Manager, Consumer Money Business), SoFi Technologies (SoFi Money), and BBVA (Global Head of Digital Sales and Customer Engagement).
Compensation: $475,000 initial base salary, 75% annual bonus target, $250,000 one-time sign-on bonus, RSUs with an approximate value of $8,075,000, and PSUs with an estimated value of $1,425,000.
BTCS Inc. disclosed on August 25, 2026 that on August 21, 2026 it borrowed an additional $10.0 million in USDT from the AAVE protocol, bringing total AAVE borrowings to about $53.0 million. The loan is collateralized by about 46,531 ETH valued at $112.6 million and can be partially or fully liquidated if the health factor falls below one, so the added debt increases the company's exposure to collateral value and liquidation risk.
Additional borrowing of $10.0 million in USDT on August 21, 2026; total AAVE borrowings about $53.0 million.
Collateral is about 46,531 ETH, approximately $112.6 million at an ETH price of $2,420.
Variable interest rate was about 3.98% per annum at the time of the new borrowing; no fixed maturity date.
Loan proceeds were used to buy additional ETH and USDC, deployed into liquidity pools through the Imperium business.
Quad/Graphics filed slides for presentations at the Midwest IDEAS Conference on August 26, 2026. The deck shows second-quarter 2026 net sales of $577.5 million, up from $571.9 million a year earlier, while adjusted EBITDA fell to $42.0 million from $43.3 million. Net debt leverage rose to 2.03x at June 30, 2026, from 1.57x at December 31, 2025.
Q2 2026 net sales were $577.5 million, compared with $571.9 million in Q2 2025.
Q2 2026 adjusted EBITDA was $42.0 million (7.3% margin), compared with $43.3 million (7.6% margin) in Q2 2025.
Q2 2026 adjusted diluted EPS was $0.24, compared with $0.14 in Q2 2025; net earnings were $3.7 million versus a $0.1 million loss.
Net Debt Leverage Ratio was 2.03x at June 30, 2026, versus 1.57x at December 31, 2025; the 2026 guidance range for adjusted EBITDA is $175 million to $215 million.
Richtech Robotics said its board authorized repurchases of up to $12 million of Class B common stock, effective August 21, 2026, with the program running through August 21, 2027. The company said the program does not obligate it to buy any specific number of shares and may be changed or ended at any time, so the buyback's effect on shareholders depends on how much stock the company actually repurchases. The filing also reports a $750 per bi-weekly healthcare cash stipend for the CEO, CFO and COO.
Board authorized repurchases of up to $12 million of Class B common stock, effective August 21, 2026, through August 21, 2027
Repurchases to be made under a Rule 10b5-1 trading plan, subject to plan terms and market conditions
Company is not obligated to repurchase any specific number of shares; the board may modify, suspend or terminate the program without notice
Compensation committee approved a $750 healthcare cash stipend per bi-weekly paycheck for the CEO, CFO and COO, or about $19,500 annually in aggregate
Marzetti reported fourth-quarter and fiscal 2026 results for the period ended June 30, 2026. Quarterly net sales fell 2.2% to $465.0 million, while net income rose to $48.3 million, helped by an $18.5 million gain on the sale of its Milpitas, California, property, and adjusted diluted EPS rose 9.0% to $1.46. For shareholders the picture is mixed: reported quarterly sales declined and part of the profit gain came from the one-time property gain, though fiscal 2026 net income rose to $191.6 million and operating cash flow reached a record $283.8 million.
Fourth-quarter net sales were $465.0 million, down 2.2%, or up 0.4% excluding $12.2 million of prior-year temporary supply agreement sales with Winland Foods.
The Bachan's acquisition, which closed May 1, 2026, added $15.4 million of fourth-quarter Retail segment sales.
Fiscal 2026 net income was $191.6 million, or $6.98 per diluted share, versus $6.07 a year earlier; adjusted diluted EPS was $6.83 versus $6.72.
Fiscal 2026 cash dividends totaled $108.8 million and share repurchases totaled $36.3 million; the company increased its regular dividend for the 63rd consecutive year.
Incannex Healthcare announced on August 25, 2026 that the first patient has been dosed in the DReAMzz Phase 2 dose-optimization study of IHL-42X, its oral drug candidate for obstructive sleep apnea. The company says the study is designed to inform dose selection for its planned Phase 3 program. The filing contains no financial results, guidance or funding figures.
First patient dosed in the DReAMzz Phase 2 study, announced August 25, 2026
All 14 DReAMzz sites have Institutional Review Board approval, and the study uses 14 clinical trial sites across the United States
Builds on prior Phase 2 RePOSA results showing statistically significant AHI reductions versus placebo, with individual reductions of up to 83%, and FDA Fast Track designation for IHL-42X
Boxlight amended its inventory finance agreement with J.J. Astor, a related party whose CEO is the chairman of Boxlight's board, Michael Pope. Under two amendments, the company converted $75,608.38 and $92,357.55 of the outstanding balance into common stock at $2.49615 per share. The filing shows the debt reduction and the new share issuance, which increases the number of shares outstanding.
August 17, 2026: $75,608.38 of debt converted into 30,290 shares at $2.49615 per share under the Second Amendment
August 19, 2026: $92,357.55 of debt converted into 37,000 shares at $2.49615 per share under the Third Amendment
J.J. Astor is beneficially owned by a private investment fund managed by Michael Pope, chairman and principal executive officer of Boxlight
The inventory finance agreement was originally dated May 27, 2025, amended and restated November 3, 2025, and previously amended April 1, 2026
SelectQuote reported fourth-quarter fiscal 2026 revenue of $321.7 million, down from $345.1 million a year earlier, and a net loss of $16.8 million, compared with net income of $12.9 million in the prior-year quarter. Adjusted EBITDA rose to $11.9 million from $2.7 million, and cash used in operations narrowed to $3.3 million from $37.5 million. The company also gave fiscal 2027 guidance of $1.35 billion to $1.45 billion in revenue and $90 million to $115 million in Adjusted EBITDA.
Q4 fiscal 2026 revenue was $321.7 million versus $345.1 million in Q4 fiscal 2025; net loss was $16.8 million versus net income of $12.9 million
Q4 Adjusted EBITDA was $11.9 million versus $2.7 million a year earlier; fiscal 2026 Adjusted EBITDA was $109.1 million versus $126.3 million
Fiscal 2026 net income was $62.2 million and operating cash flow was $31.9 million, a $44 million improvement over fiscal 2025
Fiscal 2027 guidance: revenue of $1.35 billion to $1.45 billion, Adjusted EBITDA of $90 million to $115 million, and operating cash flow of more than $60 million
DICK'S reported second-quarter 2026 GAAP net sales of $5.6 billion, up from $3.6 billion a year earlier, mainly because of the Foot Locker acquisition, while GAAP earnings per diluted share fell 26% to $3.50. The company lowered its full-year 2026 Foot Locker comparable sales and operating income outlook, citing challenging athletic footwear conditions, but kept its DICK'S Business comparable sales outlook unchanged, which matters to shareholders because Foot Locker now makes up a large share of results.
Q2 GAAP EPS $3.50 vs. $4.71 a year earlier; non-GAAP EPS $3.53 vs. $4.38; 9.6 million shares issued for Foot Locker dilute per-share results.
DICK'S Business comparable sales rose 4.9%; Foot Locker proforma comparable sales fell 3.6%.
Full-year 2026 outlook: Foot Locker comparable sales now negative 2.0% to 0.0% and Foot Locker segment loss of $(80) million to $(40) million; DICK'S comparable sales outlook maintained at 2.5% to 4.0%.
Quarterly dividend of $1.25 per share, payable September 25, 2026, to holders of record on September 11, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.